{"id":101,"date":"2023-10-02T11:28:12","date_gmt":"2023-10-02T16:28:12","guid":{"rendered":"https:\/\/nomodeaths.mimh.edu\/?page_id=101"},"modified":"2026-04-16T15:49:46","modified_gmt":"2026-04-16T20:49:46","slug":"stimulant-use-disorder","status":"publish","type":"page","link":"https:\/\/nomodeaths.org\/index.php\/stimulant-use-disorder\/","title":{"rendered":"Stimulant Use Disorder"},"content":{"rendered":"

[et_pb_section fb_built=”1″ _builder_version=”4.23″ _module_preset=”default” global_colors_info=”{}”][et_pb_row column_structure=”2_5,3_5″ _builder_version=”4.23″ _module_preset=”default” locked=”off” global_colors_info=”{}”][et_pb_column type=”2_5″ _builder_version=”4.23″ _module_preset=”default” global_colors_info=”{}”][et_pb_image src=”https:\/\/nomodeaths.org\/wp-content\/uploads\/2023\/12\/SUD-IMage.png” title_text=”SUD Image” align=”center” _builder_version=”4.23″ _module_preset=”default” module_alignment=”right” max_height=”236px” global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][et_pb_column type=”3_5″ _builder_version=”4.23″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.23″ _module_preset=”default” text_font=”PT Serif||||||||” text_text_color=”#000000″ header_font=”Open Sans|700|||||||” width=”100%” global_colors_info=”{}”]<\/p>\n

The State Opioid Response and Stimulant Use Disorder<\/span><\/h1>\n

The second round of Missouri State Opioid Response project\u2019s scope of coverage expanded as of October 2020 to include Stimulant Use Disorder (StimUD). The Addiction Science Team at UMSL-MIMH have put together trainings and infographics to help inform treatment and social service staff, individuals in active use, and others about the basics of stimulant use and StimUD. Additionally, this page highlights supportive resources to find treatment options for StimUD as well as links for further information on this important topic as stimulant-related deaths are becoming a growing concern in Missouri.<\/span><\/p>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.23″ _module_preset=”default” background_color=”rgba(255,255,255,0.75)” background_image=”https:\/\/nomodeaths.org\/wp-content\/uploads\/2024\/01\/pexels-shonejai-1227511-1.jpg” background_blend=”overlay” box_shadow_style=”preset6″ box_shadow_spread=”15px” box_shadow_color=”rgba(0,0,0,0.28)” locked=”off” global_colors_info=”{}”][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.23″ _module_preset=”default” background_color=”#efefef” locked=”off” global_colors_info=”{}”][et_pb_row column_structure=”1_3,1_3,1_3″ use_custom_gutter=”on” _builder_version=”4.23″ _module_preset=”default” positioning=”none” max_width=”1350px” module_alignment=”center” global_colors_info=”{}”][et_pb_column type=”1_3″ _builder_version=”4.23″ _module_preset=”default” global_colors_info=”{}”][et_pb_cta title=”Contingency Management Interventions” button_url=”https:\/\/attcnetwork.org\/centers\/attc-network-coordinating-office\/contingency-management-part-1-evidenced-based-approach” url_new_window=”on” button_text=”Learn more” _builder_version=”4.23″ _module_preset=”default” header_font=”Open Sans||||||||” header_text_align=”center” header_text_color=”#000000″ body_font=”PT Serif||||||||” body_text_color=”#000000″ background_color=”#ffffff” button_icon=”=||divi||400″ button_alignment=”center” text_orientation=”left” link_option_url_new_window=”on” border_radii=”on|10px|10px|10px|10px” border_width_all=”3px” border_color_all=”#c0c182″ box_shadow_style=”preset2″ global_colors_info=”{}”]<\/p>\n

\"\"<\/p>\n

The SOR grant <\/span>utilizes<\/span> Contingency Management in s<\/span>elected <\/span>Substance Use <\/span>Disorder<\/span> treatment facilities across the state of Missouri. Contingency Man<\/span>ageme<\/span>nt <\/span>is as<\/span> an evidence-based intervention for increasing engagement and retention with people in treatm<\/span>ent fo<\/span>r <\/span>StimUD<\/span>. Contingency Management involves giving patients tangible rewards (e.g., gift cards, prizes) to reinforce positive behaviors such as attending appointments or engaging in healthy outside activities.<\/span><\/span>\u00a0<\/span><\/p>\n

[\/et_pb_cta][\/et_pb_column][et_pb_column type=”1_3″ _builder_version=”4.23″ _module_preset=”default” global_colors_info=”{}”][et_pb_cta title=”Targeted StimUD Trainings” button_url=”https:\/\/missouri.qualtrics.com\/jfe\/form\/SV_5d7bLf8FmQ1Ern8″ url_new_window=”on” button_text=”Request Training” _builder_version=”4.23″ _module_preset=”default” header_font=”Open Sans||||||||” header_text_align=”center” header_text_color=”#000000″ body_font=”PT Serif||||||||” body_text_color=”#000000″ background_color=”#ffffff” button_icon=”=||divi||400″ button_alignment=”center” text_orientation=”left” link_option_url_new_window=”on” border_radii=”on|10px|10px|10px|10px” border_width_all=”3px” border_color_all=”#c0c182″ box_shadow_style=”preset2″ global_colors_info=”{}”]<\/p>\n

\"\"<\/span><\/p>\n

The SOR 2.0 grant includes efforts to educate, de-stigmatize, and prevent overdose and overamping-related deaths across the state of Missouri. Working with a diverse team of consultants, SOR grant staff can connect you to a consultant who can lead trainings on a wide variety of topics including but not limited to: the state of stimulant use in Missouri, overamping and community health strategies, information regarding stimulants among targeted populations, as well as more directed, programmatic trainings for staff. To get connected to a consultant, email: <\/span>nomodeaths@mimh.edu<\/strong><\/a><\/p>\n

[\/et_pb_cta][\/et_pb_column][et_pb_column type=”1_3″ _builder_version=”4.23″ _module_preset=”default” global_colors_info=”{}”][et_pb_cta title=”American Society of Addiction Medicine Clinical Practice Gudielines” button_url=”https:\/\/www.asam.org\/quality-care\/clinical-guidelines\/stimulant-use-disorders” url_new_window=”on” button_text=”Get the guide” _builder_version=”4.23″ _module_preset=”default” header_font=”Open Sans||||||||” header_text_align=”center” header_text_color=”#000000″ body_font=”PT Serif||||||||” body_text_color=”#000000″ background_color=”#ffffff” button_icon=”=||divi||400″ button_alignment=”center” text_orientation=”left” link_option_url=”https:\/\/www.asam.org\/quality-care\/clinical-guidelines\/stimulant-use-disorders” link_option_url_new_window=”on” border_radii=”on|10px|10px|10px|10px” border_width_all=”3px” border_color_all=”#c0c182″ box_shadow_style=”preset2″ global_colors_info=”{}”]<\/p>\n

\"\"<\/p>\n

Developed by ASAM and AAAP, this guideline focuses on the identification, diagnosis, treatment, and promotion of recovery for patients with stimulant use disorder, stimulant intoxication, and stimulant withdrawal.<\/p>\n

This Guideline aims to assist clinicians in treating individuals with StUD (including adolescents and individuals who are pregnant), as well as individuals experiencing stimulant intoxication or withdrawal, and individuals who are at high risk of developing StUD. This Guideline draws on existing empirical evidence and clinical judgment with the goal of improving the quality of care for people with StUD.<\/p>\n

[\/et_pb_cta][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.23″ _module_preset=”default” background_color=”#efefef” locked=”off” global_colors_info=”{}”][et_pb_row _builder_version=”4.23″ _module_preset=”default” locked=”off” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.23″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.23″ _module_preset=”default” text_font=”PT Serif||||||||” text_text_color=”#000000″ header_font=”Open Sans|700|||||||” width=”100%” global_colors_info=”{}”]<\/p>\n

Additional Stimulant Use Disorder Information\u00a0<\/span><\/span><\/h1>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_3,1_3,1_3″ use_custom_gutter=”on” _builder_version=”4.23″ _module_preset=”default” max_width=”800px” locked=”off” global_colors_info=”{}”][et_pb_column type=”1_3″ _builder_version=”4.23″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.23″ _module_preset=”default” text_font=”PT Serif||||||||” text_text_color=”#000000″ background_color=”#fcfeff” link_option_url=”https:\/\/nomodeaths.org\/wp-content\/uploads\/2023\/12\/PharmacoRxCocaine.pdf” link_option_url_new_window=”on” border_radii=”on|10px|10px|10px|10px” border_width_all=”3px” border_color_all=”#c0c182″ box_shadow_style=”preset1″ global_colors_info=”{}” box_shadow_vertical__hover_enabled=”on|desktop”]<\/p>\n

Pharmacotherapeutic strategies for treating cocaine use disorder–what do we have to offer?<\/p>\n

[\/et_pb_text][\/et_pb_column][et_pb_column type=”1_3″ _builder_version=”4.23″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.23″ _module_preset=”default” text_font=”PT Serif||||||||” text_text_color=”#000000″ background_color=”#fcfeff” link_option_url=”https:\/\/nomodeaths.org\/wp-content\/uploads\/2023\/12\/NTXbupriopionNEJMmethamphetamine.pdf” link_option_url_new_window=”on” border_radii=”on|10px|10px|10px|10px” border_width_all=”3px” border_color_all=”#c0c182″ box_shadow_style=”preset1″ global_colors_info=”{}” box_shadow_vertical__hover_enabled=”on|desktop”]<\/p>\n

Bupropion and Naltrexone in Methamphetamine Use Disorder<\/p>\n

[\/et_pb_text][et_pb_text _builder_version=”4.23″ _module_preset=”default” text_font=”PT Serif||||||||” text_text_color=”#000000″ background_color=”#fcfeff” link_option_url=”https:\/\/nomodeaths.org\/wp-content\/uploads\/2023\/12\/CocaineTreatmentReviewKampman.pdf” link_option_url_new_window=”on” border_radii=”on|10px|10px|10px|10px” border_width_all=”3px” border_color_all=”#c0c182″ box_shadow_style=”preset1″ global_colors_info=”{}” box_shadow_vertical__hover_enabled=”on|desktop”]<\/p>\n

The treatment of cocaine use disorder<\/p>\n

[\/et_pb_text][\/et_pb_column][et_pb_column type=”1_3″ _builder_version=”4.23″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.23″ _module_preset=”default” text_font=”PT Serif||||||||” text_text_color=”#000000″ background_color=”#fcfeff” link_option_url=”https:\/\/nomodeaths.org\/wp-content\/uploads\/2023\/12\/MedicationOptionsforTreatmentofStimulantUseDisorders-OptimisticUpdateandNewResearch.pdf” link_option_url_new_window=”on” border_radii=”on|10px|10px|10px|10px” border_width_all=”3px” border_color_all=”#c0c182″ box_shadow_style=”preset1″ global_colors_info=”{}” box_shadow_vertical__hover_enabled=”on|desktop”]<\/p>\n

Medication Options for Treatment of Stimulant Use Disorder: Optimistic Update and New Research<\/p>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"

The State Opioid Response and Stimulant Use Disorder The second round of Missouri State Opioid Response project\u2019s scope of coverage expanded as of October 2020 to include Stimulant Use Disorder (StimUD). The Addiction Science Team at UMSL-MIMH have put together trainings and infographics to help inform treatment and social service staff, individuals in active use, […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"class_list":["post-101","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/nomodeaths.org\/index.php\/wp-json\/wp\/v2\/pages\/101","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nomodeaths.org\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/nomodeaths.org\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/nomodeaths.org\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nomodeaths.org\/index.php\/wp-json\/wp\/v2\/comments?post=101"}],"version-history":[{"count":12,"href":"https:\/\/nomodeaths.org\/index.php\/wp-json\/wp\/v2\/pages\/101\/revisions"}],"predecessor-version":[{"id":1394,"href":"https:\/\/nomodeaths.org\/index.php\/wp-json\/wp\/v2\/pages\/101\/revisions\/1394"}],"wp:attachment":[{"href":"https:\/\/nomodeaths.org\/index.php\/wp-json\/wp\/v2\/media?parent=101"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}